Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
Abstract Introduction Oligomeric amyloid-ß is a major toxic species associated with Alzheimer’s disease pathogenesis. Methods used to measure oligomeric amyloid-β in the blood have increased in number in recent years. The Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) is a specific method...
Main Authors: | Young Chul Youn, Sungmin Kang, Jeewon Suh, Young Ho Park, Min Ju Kang, Jung-Min Pyun, Seong Hye Choi, Jee Hyang Jeong, Kyung Won Park, Ho-Won Lee, Seong Soo A. An, Jacqueline C. Dominguez, SangYun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13195-019-0499-7 |
Similar Items
-
Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
by: Pyun JM, et al.
Published: (2021-04-01) -
Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data
by: Young Chul Youn, et al.
Published: (2022-11-01) -
Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
by: Seong Soo A. An, et al.
Published: (2017-10-01) -
Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
by: Rosha Babapour Mofrad, et al.
Published: (2021-07-01) -
Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
by: Jung-Min Pyun, et al.
Published: (2023-01-01)